Ocular Therapeutix (OCUL)
Nasdaq • OCUL • US67576A1007
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 15.9% of free float sold short, 8.2 days to cover, cost to borrow 0.4%. Sign up for live short interest data.
Market Cap
1.45b USD | # 4376 in US
Volume
3.11m shares | 27.41m USD
Shares Outstanding
219.62m
Free Float Shares
84.10% | 184.69m
